ASCO: Avastin Improves Survival in Advanced Cervical Cancer | Cancer Network

ASCO: Avastin Improves Survival in Advanced Cervical Cancer | Cancer Network

瀏覽:1108
日期:2025-10-21
Results from the phase III GOG 240 trial, presented at ASCO, showed the addition of bevacizumab (Avastin) to standard chemotherapy improved overall survival by nearly 4 months in women with advanced or relapsed cervical cancer....看更多